Federal judge sentences Purdue Pharma to $5.5 billion in criminal penalties
A federal judge sentenced OxyContin manufacturer Purdue Pharma to $5.5 billion in criminal penalties on Tuesday, marking the final step before the company's dissolution. The sentence resolves the Department of Justice's criminal fraud case against Purdue, which pleaded guilty in 2020 to deceiving regulators and paying kickbacks. The company will be replaced by Knoa Pharma, focused on addressing the opioid crisis.
8
Divergence score
2 outlets covered it, splitting into 2 framing camps across 2 bias groups.
2 camps
2 bias groups
The spectrum · how 2 outlets placed this story
LeftCenterRight
Washington Examiner
Reuters
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
Widest split · the two outlets furthest apart, and who published first
Furthest apart on this story
Washington Examiner
OxyContin maker Purdue Pharma set to dissolve after judge approves sentence
company dissolution and crisis mitigation · positive
Reuters
Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement
sentence enables settlement process · neutral
First to report
- Reutersfirst
- Washington Examiner+10.4 h
By each outlet's earliest publish time in this story. Feeds that index slowly can appear later than they printed.
The split, in one line
The Washington Examiner emphasizes Purdue's replacement by Knoa Pharma and frames it as addressing the opioid crisis, while Reuters focuses on the sentence enabling settlement for individual lawsuits.
How each outlet covered it
Lightly covered so far
Too few outlets to map a left-right split. Here is each take as it stands.
Sparse coverage · 2 outlets
“Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement”
“OxyContin maker Purdue Pharma set to dissolve after judge approves sentence”
5 tracked claims across 2 outlets
Fact ledger
All5Claimed3Corroborated2
1/2
Claimed
Purdue Pharma will be replaced by Knoa Pharma, aimed at providing relief and addressing the opioid crisis
Source ·Washington Examiner claims Purdue will be replaced by Knoa Pharma; Reuters article excerpt does not address replacement
Corroborated
Disputed
4 more tracked claimsSign up free to see the full ledger